First Tracks Biotherapeutics, Inc. (TRAX)

Last Closing Price: 40.46 (2026-09-04)

EBIT Margin (Quarterly)

EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues

First Tracks Biotherapeutics, Inc. (TRAX) EBIT Margin data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
--
$-33.37M
--
--
$34.94M
$-34.94M
$1.56M
$-33.37M
$-33.37M
$-33.37M
$-33.37M
$-33.37M
$-33.37M
$-34.94M
$-34.58M
35.00M
35.00M
$-0.95
$-0.95
Balance Sheet Financials
$177.75M
$1.07M
$5.39M
$183.14M
$12.45M
--
$1.90M
$14.34M
$168.80M
$168.80M
$168.80M
35.39M
Cash Flow Statement Financials
$-64.48M
$34.96M
$-40.66M
$238.20M
$168.02M
$-70.18M
$19.82M
--
--
Fundamental Metrics & Ratios
14.28
--
--
--
--
--
--
EBIT Margin
--
--
--
--
$-64.52M
--
--
--
--
--
--
--
-19.77%
-19.77%
-18.22%
-19.77%
$4.77
$-1.84
$-1.84